Finance

Lists
Why is FORTIS down 6,94%?
Dive Deeper
FORTIS:NSE
Fortis Healthcare Ltd
₹764,95
-6,94%
(-57,05) 1D
30 Sep., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for FORTIS...
Open
₹817,00
High
₹821,00
Low
₹757,45
Mkt. cap
579,61 mjd
Avg. vol.
1,18 m
Volume
5,82 m
Dividend
0,13%
Quarterly dividend
₹0,25
Ex-dividend date
24 Jul. 2026
P/E ratio
55,12
52-wk high
₹1 104,30
52-wk low
₹757,45
EPS
₹13,88
Shares outstanding
519,08 m
No. of employees
15 k
Open
₹817,00
High
₹821,00
Low
₹757,45
Mkt. cap
579,61 mjd
Avg. vol.
1,18 m
Volume
5,82 m
Dividend
0,13%
Quarterly dividend
₹0,25
Ex-dividend date
24 Jul. 2026
P/E ratio
55,12
52-wk high
₹1 104,30
52-wk low
₹757,45
EPS
₹13,88
Shares outstanding
519,08 m
No. of employees
15 k
News stories
From web sources and news partners
Profile
Fortis Healthcare Limited is an Indian for-profit private hospital network headquartered in Gurgaon. The Fortis Memorial Research Institute in Gurgaon serves as the headquarters for Fortis Healthcare. In addition to its Gurgaon facility, Fortis Healthcare operates hospitals in the Delhi NCR, including locations in Faridabad, Noida, Vasant Kunj, and Shalimar Bagh, along with other facilities across India, Dubai, and Sri Lanka. The company currently manages 36 healthcare facilities. Wikipedia
About Fortis Healthcare Ltd
CEOAshutosh Raghuvanshi
Employees14,6 k
Founded1996
HeadquartersGurugram, Haryana, Indië
SectorHealth care provider
Websitefortishealthcare.com
Last report
07 Aug. 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹3,62 / ₹3,75
-3,42%miss
Revenue / Est. (INR)
25,45 mjd / 25,08 mjd
+1,47%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
23,31 mjd
22,65 mjd
23,65 mjd
25,45 mjd
Cost of goods sold
13,50 mjd
13,37 mjd
-3,56 mjd
15,29 mjd
Cost of revenue
13,50 mjd
13,37 mjd
-3,56 mjd
15,29 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
4,29 mjd
-
Operating expense
5,31 mjd
5,42 mjd
23,22 mjd
6,01 mjd
Total operating expenses
18,81 mjd
18,80 mjd
19,66 mjd
21,30 mjd
Operating income
4,50 mjd
3,86 mjd
3,98 mjd
4,15 mjd
Other non operating income
225,80 m
82,90 m
-709,53 m
144,70 m
EBT including unusual items
4,25 mjd
2,66 mjd
3,24 mjd
3,63 mjd
EBT excluding unusual items
4,02 mjd
3,12 mjd
3,33 mjd
3,54 mjd
Income tax expense
965,80 m
682,80 m
530,11 m
903,80 m
Effective tax rate
22,70%
25,70%
16,35%
24,89%
Other operating expenses
4,25 mjd
4,22 mjd
17,71 mjd
4,79 mjd
Net income
3,22 mjd
1,94 mjd
2,66 mjd
2,66 mjd
Net profit margin
13,81%
8,55%
11,24%
10,47%
Earnings per share
4,02
3,02
3,66
3,62
Interest and investment income
-
-
394,31 m
-
Interest expense
-748,80 m
-857,40 m
-402,06 m
-804,40 m
Net interest expenses
-748,80 m
-857,40 m
-7,74 m
-804,40 m
Depreciation and amortization charges
1,06 mjd
1,20 mjd
1,22 mjd
1,22 mjd
EBITDA
5,54 mjd
4,62 mjd
4,87 mjd
5,04 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme